title: Azathioprine and cyclophosphamide as slow-acting drugs for rheumatoid arthritis.
abstract: Therapy with azathioprine and cyclophosphamide is described as reducing disease activity in rheumatoid arthritis. The well recognized untoward effects are tractable save for the definite augmentation of carcinogenesis, a measurable risk that is regarded as acceptable in treating rheumatoid arthritis with azathioprine and rheumatoid arteritis with cyclophosphamide.
mesh_terms: D001167:Arteritis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced
chemical_list: D003520:Cyclophosphamide; D001379:Azathioprine